Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chester B Whitley

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
American Journal of Medical Genetics. Part A|March 3, 2025
Detecting the Difficult: An Intronic NPC1 Variant Hiding in Plain SightCaroline Gully Brown, Matthew Bower, Matthew Schomaker, et al.
International Journal of Neonatal Screening|March 27, 2026
Beyond Detection: Comparing State-Based Newborn Screening Methods for Effective Mucopolysaccharidosis I DiagnosisRithika Thampy, Nishitha R Pillai, Michael Evans, et al.
JIMD Reports|January 17, 2025
Phenotypic variability and the gender paradox in the R363C variant of Fabry diseaseAlison C Leslie, Jeanine Jarnes, Alia Ahmed, et al.
Expert Opinion on Drug Delivery|December 17, 2014
Gene therapy for neurologic manifestations of mucopolysaccharidosesDaniel A Wolf, Sharbani Banerjee, Perry B Hackett, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 14, 2020
Sebelipase alfa for lysosomal acid lipase deficiency: 5-year treatment experience from a phase 2 open-label extension studyVĕra Malinová, Manisha Balwani, Reena Sharma, et al.
Molecular Genetics and Metabolism|May 7, 2017
Infantile gangliosidoses: Mapping a timeline of clinical changesJeanine R Jarnes Utz, Sarah Kim, Kelly King, et al.
Journal of Clinical and Experimental Neuropsychology|June 11, 2013
Mucopolysaccharidosis Type IIIA presents as a variant of Klüver-Bucy syndromeMichael Potegal, Brianna Yund, Kyle Rudser, et al.
Molecular Genetics and Metabolism|March 19, 2022
Quantifying medical manifestations in Hurler syndrome with the infant physical symptom score: associations with long-term physical and adaptive outcomesAlia Ahmed, Kyle Rudser, Kelly E King, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2002
Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrowDao Pan, Roland Gunther, Weiming Duan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 13, 2020
A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type ILi Ou, Michael J Przybilla, Ozan Ahlat, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
American Journal of Medical Genetics. Part A|March 3, 2025
Detecting the Difficult: An Intronic NPC1 Variant Hiding in Plain SightCaroline Gully Brown, Matthew Bower, Matthew Schomaker, et al.
International Journal of Neonatal Screening|March 27, 2026
Beyond Detection: Comparing State-Based Newborn Screening Methods for Effective Mucopolysaccharidosis I DiagnosisRithika Thampy, Nishitha R Pillai, Michael Evans, et al.
JIMD Reports|January 17, 2025
Phenotypic variability and the gender paradox in the R363C variant of Fabry diseaseAlison C Leslie, Jeanine Jarnes, Alia Ahmed, et al.
Expert Opinion on Drug Delivery|December 17, 2014
Gene therapy for neurologic manifestations of mucopolysaccharidosesDaniel A Wolf, Sharbani Banerjee, Perry B Hackett, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 14, 2020
Sebelipase alfa for lysosomal acid lipase deficiency: 5-year treatment experience from a phase 2 open-label extension studyVĕra Malinová, Manisha Balwani, Reena Sharma, et al.
Molecular Genetics and Metabolism|May 7, 2017
Infantile gangliosidoses: Mapping a timeline of clinical changesJeanine R Jarnes Utz, Sarah Kim, Kelly King, et al.
Journal of Clinical and Experimental Neuropsychology|June 11, 2013
Mucopolysaccharidosis Type IIIA presents as a variant of Klüver-Bucy syndromeMichael Potegal, Brianna Yund, Kyle Rudser, et al.
Molecular Genetics and Metabolism|March 19, 2022
Quantifying medical manifestations in Hurler syndrome with the infant physical symptom score: associations with long-term physical and adaptive outcomesAlia Ahmed, Kyle Rudser, Kelly E King, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2002
Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrowDao Pan, Roland Gunther, Weiming Duan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 13, 2020
A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type ILi Ou, Michael J Przybilla, Ozan Ahlat, et al.
Pageof 12